Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-004458

CBO & COO sold 25,000 shares at an average $215.20 ($5,379,940)

  • CBO & COO acquired 25,010 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2021-01-15 Option exercise +8,666 $12.57 $108,932 28,666 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −2,911 $211.44 $615,502 25,755 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −2,555 $212.54 $543,040 23,200 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −1,200 $213.71 $256,452 22,000 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −1,400 $214.46 $300,244 20,600 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −400 $216.24 $86,496 20,200 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −200 $217.45 $43,490 20,000 D
Klein Lawrence Otto CBO & COO 2021-01-15 Option exercise +16,344 $14.43 $235,844 36,334 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −634 $212.20 $134,535 35,700 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −2,800 $213.64 $598,192 32,900 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −700 $214.60 $150,220 32,200 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −1,500 $216.39 $324,585 30,700 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −9,997 $217.42 $2,173,548 20,703 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −701 $218.54 $153,197 20,002 D
Klein Lawrence Otto CBO & COO 2021-01-15 Sale −2 $219.99 $440 20,000 D
Derivatives
Klein Lawrence Otto CBO & COO 2021-01-15 Option exercise · Stock Option (Right to Buy) −8,666 0 D
Klein Lawrence Otto CBO & COO 2021-01-15 Option exercise · Stock Option (Right to Buy) −16,334 14,666 D
Open-market sales · 25,000 sh · avg $215.20 · $5,379,940
Loading xslF345X03/doc4.xml…